Dutch Life Science Database

News in the Life Sciences Industry
Results 1 - 20 out of 157 displayed.
1 2 3 4 5 6 7 8 »

Wright Medical Group N.V. to Host Fourth Quarter 2018 Earnings Conference Call

By: Nasdaq / GlobenewsWire - 22 Jan 2019

Related companies: WRIGHT MEDICAL GROUP N.V.

Dr. Johan Luthman appointed EVP and Head of Research & Development in Lundbeck

By: Nasdaq / GlobenewsWire - 22 Jan 2019

Mundipharma to Provide Access to Breakthrough Cold-Fighting Product for Adults and Children in the Middle East and Africa

SINGAPORE, Jan. 22, 2019 /PRNewswire/ -- Mundipharma will be introducing BETADINE(TM) Cold Defence, a new early treatment hailed as a "world-first" ([i]), in the Middle East and Africa to help families stay healthy and fight the common cold.

By: PR Newswire Association LLC. - 22 Jan 2019

Novo Nordisk A/S - Share repurchase programme

By: Nasdaq / GlobenewsWire - 21 Jan 2019

Sanofi: FDA advisory committee votes on Zynquista(TM) (sotagliflozin) as treatment for adults with type 1 diabetes

By: Nasdaq / GlobenewsWire - 18 Jan 2019

Virbac : 2018 annual revenue grew by +4.5% at constant exchange rates

By: Nasdaq / GlobenewsWire - 17 Jan 2019

Philips launches Azurion with FlexArm to set new standard for the future of image-guided procedures

AMSTERDAM, Jan. 17, 2019 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced Azurion... Read more ››

By: PR Newswire Association LLC. - 17 Jan 2019

Large-scale paediatric SLIT-tablet trial meets primary endpoint, confirming potential in children

By: Nasdaq / GlobenewsWire - 15 Jan 2019

Information concerning the total number of voting rights and shares

By: Nasdaq / GlobenewsWire - 15 Jan 2019

ALK's Board of Directors to nominate Vincent Warnery as new member of the Board

By: Nasdaq / GlobenewsWire - 15 Jan 2019

Novo Nordisk A/S - Share repurchase programme

By: Nasdaq / GlobenewsWire - 14 Jan 2019

MDxHealth (R): MDxHealth Provides Business Update

By: Nasdaq / GlobenewsWire - 14 Jan 2019

Related companies: MDXHEALTH, INC | MDxHealth B.V. | MDxHealth S.A.

Mundipharma to Bring World's First Gene Therapy for Osteoarthritis to Nine More Countries in APAC

SINGAPORE, Jan. 14, 2019 /PRNewswire/ -- Mundipharma has acquired the exclusive rights for Invossa(®)-K in Singapore, Malaysia, the Philippines, Thailand, Vietnam, Indonesia, Myanmar, Australia and New Zealand from Kolon Life Sciences. Invossa(®)-K is a non-surgical treatment for osteoarthritis... Read more ››

By: PR Newswire Association LLC. - 14 Jan 2019

Related companies: Esperite N.V.

ProQR Reaches Agreement with the FDA on Design of Phase 2/3 Pivotal Trial for Sepofarsen (QR-110) for Leber’s Congenital Amaurosis 10

By: Nasdaq / GlobenewsWire - 07 Jan 2019

Related companies: ProQR Therapeutics NV

1 2 3 4 5 6 7 8 »

Looking for companies outside of Netherlands?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

February 2019
- Zurich: Swiss Nordic Bio 2019
- New York: BIO CEO & Investor Conference
March 2019
- Tokyo: BIO Asia International Conference

See Events »

Add an Event »

Latest company news

Wright Medical Group N.V. to Host Fourth Quarter 2018 Earnings Conference Call
22 Jan 2019 (Nasdaq / GlobenewsWire)

Dr. Johan Luthman appointed EVP and Head of Research & Development in Lundbeck
22 Jan 2019 (Nasdaq / GlobenewsWire)

Mundipharma to Provide Access to Breakthrough Cold-Fighting Product for Adults and Children in the Middle East and Africa
22 Jan 2019 (PR Newswire Association LLC.)

News in the Life Sciences Industry

Wright Medical Group N.V. to Host Fourth Quarter 2018 Earnings Conference Call

Dr. Johan Luthman appointed EVP and Head of Research & Development in Lundbeck

Mundipharma to Provide Access to Breakthrough Cold-Fighting Product for Adults and Children in the Middle East and Africa

Novo Nordisk A/S - Share repurchase programme

Sanofi: FDA advisory committee votes on Zynquista(TM) (sotagliflozin) as treatment for adults with type 1 diabetes

Virbac : 2018 annual revenue grew by +4.5% at constant exchange rates

Philips launches Azurion with FlexArm to set new standard for the future of image-guided procedures

Large-scale paediatric SLIT-tablet trial meets primary endpoint, confirming potential in children

Information concerning the total number of voting rights and shares

ALK's Board of Directors to nominate Vincent Warnery as new member of the Board

Novo Nordisk A/S - Share repurchase programme

MDxHealth (R): MDxHealth Provides Business Update

Mundipharma to Bring World's First Gene Therapy for Osteoarthritis to Nine More Countries in APAC

Sanofi: Availability of the Pre-quarterly Results Communication

ALK appoints new Head of Product Supply

ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 24th tranche of investment today

ProQR Reaches Agreement with the FDA on Design of Phase 2/3 Pivotal Trial for Sepofarsen (QR-110) for Leber’s Congenital Amaurosis 10

Novo Nordisk A/S - Share repurchase programme

Virbac : Declaration of the number of shares and voting rights as of December 2018, 31.

Sanofi and Regeneron Restructure Immuno-Oncology Collaboration for Discovery and Development Programs

Looking for companies outside of Netherlands?

Partners

Upcoming Life Sciences Events

Latest company news